Compare BTBT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTBT | BVS |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.7M | 617.1M |
| IPO Year | 2017 | 2016 |
| Metric | BTBT | BVS |
|---|---|---|
| Price | $1.31 | $8.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $6.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 15.7M | 407.2K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | $113,560,320.00 | ★ $568,087,000.00 |
| Revenue This Year | $89.54 | $7.43 |
| Revenue Next Year | $48.40 | $6.61 |
| P/E Ratio | ★ N/A | $27.30 |
| Revenue Growth | ★ 5.10 | N/A |
| 52 Week Low | $1.25 | $5.81 |
| 52 Week High | $4.55 | $9.53 |
| Indicator | BTBT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 47.33 |
| Support Level | $1.25 | $8.32 |
| Resistance Level | $2.43 | $9.01 |
| Average True Range (ATR) | 0.09 | 0.36 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 14.29 | 29.57 |
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.